Mitchell, A A <br/><br/>
Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?  [electronic resource] 

 -  Drug safety   
 - 79-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-199207020-00001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abnormalities, Drug-Induced--epidemiology<br/>Adult<br/>Female<br/>Humans<br/>Infant, Newborn<br/>Isotretinoin--adverse effects<br/>Pregnancy<br/>Retinoids--adverse effects<br/>Teratogens<br/>United States--epidemiology<br/>Vitamin A--adverse effects